What Spirair learned about polydioxanone in its innovative use of the absorbable polymer for a new implant
Spirair Receives FDA Clearance for SeptAlign, the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation
New therapy provides a minimally invasive option for ENTs to straighten minor deviations in septal cartilage and help address nasal airway obstruction.
Spirair Announces Appointment of Chief Executive Officer
Spirair Announces Appointment of Chief Executive Officer Spirair is entering its next stage of growth as it prepares for commercialization.
Nose-knows: How a Stanford research project turned into a way to fix a deviated septum
Leaders of a Peninsula medical device startup believe they can straighten out nasal septal deviations for potentially hundreds of thousands of people